The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksH&t Group Plc Regulatory News (HAT)

Share Price Information for H&t Group Plc (HAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 426.00
Bid: 421.00
Ask: 440.00
Change: 11.00 (2.65%)
Spread: 19.00 (4.513%)
Open: 434.00
High: 434.00
Low: 418.00
Prev. Close: 415.00
HAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on regulatory review into HCST lending

4 Apr 2022 07:00

RNS Number : 0372H
H&T Group PLC
04 April 2022
 

H&T Group plc

("H&T" or "the Group" or "the Company")

 

Update in respect of regulatory review into high-cost short term lending

 

H&T Group plc announced on 18 November 2019 that it was working closely with the Financial Conduct Authority (FCA) to undertake via a skilled person, a review of the lending processes, credit worthiness and affordability assessments within its unsecured high-cost short term (HCST) loans business between April 2014 and October 2019 ("the review").

 

A methodology for conducting the required past book review was developed in close collaboration with the skilled person. Following an initial review by the FCA, "outcomes testing" was undertaken by the skilled person. After further review by the FCA and subsequent development of the methodology, the FCA has confirmed that H&T may now proceed to implementation of the past book review and the resulting customer redress arrangements.

 

Following application of the review methodology, it is considered that a total of c.9,800 HCST loans to c.8,000 customers should not have been granted. This represents 11.5% of HCST loans and 12.6 % of HCST customers during the period. Redress will be paid in respect of these loans in accordance with the methodology, including statutory interest up to 31 March 2022, taking account of any withholding tax.

 

In total, the cost of the redress will amount to £2.1m, of which £1.6m will be paid directly to customers and £0.5m will be by way of an adjustment to the balance of current outstanding loans. On average, eligible customers will receive redress amounting to £264.

 

Customers who are eligible to receive redress either in the form of cash or balance adjustment will be contacted directly, beginning in April 2022. The process is expected to be completed within 12 months.

 

A provision of £2.1m was raised in the Group's financial statements for the year ending 31 December 2021, to cover the cost of this redress. In addition, it is anticipated that professional, operational and implementation costs relating to the review and the redress programme will amount to approximately £0.6m. This has been fully provided for in previous accounting periods.

 

Chris Gillespie, chief executive of H&T said:

 

"The Board of H&T is very aware of the concerns and uncertainly that this review has caused for all stakeholders. We are pleased that the review is now concluded and that the majority of HCST loans granted by H&T are considered to have been lent responsibly.

 

"Customers whose loan should not have been granted and who are due redress, will be contacted directly and we will endeavour to complete the redress programme as quickly as we can, so as not to prolong the uncertainty further.

 

"H&T is committed to providing services which maintain the highest standards of customer care and regulatory compliance, and we have co-operated fully and constructively with the FCA throughout this review. High cost short term unsecured lending no longer forms part of the Group's product offering."

 

END

 

 

Enquiries:

H&T Group plc 

Tel: 020 8225 2797

Chris Gillespie, Chief Executive

Diane Giddy, Chief Financial Officer

 

Shore Capital Ltd (Nominated Adviser and Broker)

Tel: 020 7408 4090

Stephane Auton/ Iain Sexton (Corporate Advisory)

Guy Wiehahn/ Chloë Booker-Triolo (Corporate Broking)

 

Haggie Partners (Public Relations)

Tel: 020 7562 4444

Damian Beeley

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUMCCUPPGAG
Date   Source Headline
22nd Apr 202412:15 pmEQSQ&A on H&T Group (HAT): 2023 results – strong core growth
16th Apr 20247:00 amRNSAnnual Report & Notice of AGM
4th Apr 20244:57 pmEQSHardman & Co Research on H&T Group: Core franchise build, short-term retail noise
18th Mar 20243:58 pmRNSPDMR Dealing
18th Mar 20247:00 amRNSPDMR Dealing
12th Mar 20247:00 amRNSPreliminary Results
21st Feb 202411:10 amEQSQ&A on H&T Group (HAT): Long-term pawnbroking growth, short-term cost and retail pressure
21st Feb 20247:00 amRNSAcquisition and Additional Financing
23rd Jan 20245:47 pmEQSHardman & Co Research on H&T Group (HAT): Growing pawnbroking core will drive other services
23rd Jan 20247:00 amRNSTrading Update and Notice of Results
17th Nov 20237:00 amRNSAnnouncement of Additional Financing
18th Oct 20233:10 pmRNSHolding(s) in Company
17th Oct 20237:00 amRNSBlock Listing Return and Cancellation
7th Sep 20232:50 pmEQSHardman & Co Q&A on H&T Group (HAT): Seizing the pawnbroking opportunity
25th Aug 20239:15 amEQSHardman & Co Research on H&T Group (HAT): Delivering the pawnbroking growth opportunity
8th Aug 20237:00 amRNSInterim Results
24th Jul 20237:00 amRNSAnnouncement of Increased Bank Financing
17th Jul 20238:52 amRNSHolding(s) in Company
11th Jul 20237:00 amRNSTrading Update & Notice of Results
23rd Jun 20231:15 pmEQSHardman & Co Q&A on H&T Group: Why is pawnbroking so attractive at the moment?
16th Jun 20237:00 amRNSNew NED Appointments
13th Jun 20237:00 amRNSPDMR Dealing
1st Jun 20233:45 pmEQSHardman & Co Research on H&T Group (HAT): Pawnbroking’s current appeal
1st Jun 20237:00 amRNSTotal Voting Rights
15th May 20235:04 pmRNS2023 PSP and Amendment to the 2021 PSP
11th May 20234:01 pmRNSHolding(s) in Company
10th May 20232:25 pmRNSResult of Annual General Meeting
10th May 20237:00 amRNSAGM Trading Update
24th Apr 202312:28 pmRNSReplacement: Annual Report & Notice of AGM
11th Apr 20234:10 pmRNSBlocklisting Application
5th Apr 20237:00 amRNSPosting of Annual Report and Notice of AGM
3rd Apr 20232:48 pmRNSDirector/PDMR Shareholding
28th Mar 20231:34 pmRNSDirector/PDMR Shareholding
27th Mar 20234:05 pmEQSHardman & Co Q&A on H&T Group (HAT): Unique opportunities for strong, profitable growth
15th Mar 202312:15 pmEQSHardman & Co Research on H&T (initiation of coverage): Pawnbroking royalty, with strong, profitable growth
7th Mar 20237:00 amRNSPreliminary Results
18th Jan 20237:03 amRNSBoard Changes
18th Jan 20237:00 amRNSTrading Update and Notice of Results
4th Nov 20225:56 pmRNSStandard form for notification of major holdings
13th Oct 20223:57 pmRNSStandard form for notification of major holdings
5th Oct 20224:36 pmRNSStandard form for notification of major holdings
5th Oct 20223:02 pmRNSStandard form for notification of major holdings
30th Sep 20227:00 amRNSResults of Capital Raise
29th Sep 20224:47 pmRNSRetail Offer by PrimaryBid
29th Sep 20224:43 pmRNSProposed Capital Raise of up to £16.9m
9th Sep 20227:00 amRNSAppointment of Non-Executive Director
18th Aug 202210:33 amRNSHolding(s) in Company
17th Aug 20225:20 pmRNSStandard form for notification of major holdings
9th Aug 20227:00 amRNSInterim Results
8th Jul 20229:08 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.